Business Value to Operating Income Before Depreciation: 111 Inc (YI)

Corporate company logo of 111 Inc. (YI)

This daily price chart for 111, Inc. (YI) on the GURU.Markets platform shows the EV/EBITDA metric at 0.00. The company operates a leading Chinese B2B pharmaceutical marketplace, integrating cloud software into the operations of thousands of pharmacies. Automated fulfillment centers ensure efficient product distribution. Consequently, 111, Inc. (YI) is creating a large-scale omnichannel environment, serving as a key digital bridge between patients, physicians, and drug manufacturers.

YI - 111, Inc. Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization over the range 11/23/2025 - 11/10/2026

Summary analytical data breakdowns for 111.com.cn (YI)

- current price and projected stock value:
Stock Price 111 Inc.|YI - Consensus Target
- company stock exchange capitalization indicators:
Market Value 111, Inc.|YI - Enterprise Value
- company book value details:
Net Assets per Share 111, Inc.|YI - Company Book Value|Capitalization to Book Value Ratio 111.com.cn|YI - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio 111, Inc.|YI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient 111 Inc.|YI - Company Total Debt|Debts to Book Value 111, Inc|YI - Company Long-Term Debts|Short-Term Debt Volume 111, Inc.|Critical Liquidity Ratio 111.com.cn
- earnings and market ratios statistics:
YI - Net Profit|Expected Net Income 111, Inc.|YI - P/E Multiple|Forward P/E Multiple 111 Inc.|YI - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation 111, Inc.|YI - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months 111, Inc.|YI - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth 111.com.cn|YI - Earnings growth in current year|Expected earnings per share growth for next year 111, Inc.
Analysis of all company metrics:111 Inc - YI
Manufactured products of 111 Inc

This indicator compares the total enterprise value of the business with its operating profit before depreciation and amortization, allowing for an assessment of the real value of assets regardless of the tax regime and debt load. An analysis of the current EV/EBITDA value for 111, Inc. (YI) reveals capital management efficiency, which is further supported by high accounting transparency and the founders' expertise in optimizing online platforms and e-commerce sectors.

Competitors of 111, Inc.

EV/EBITDA Multiple CVS (CVS Health)|MCK - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation Cencora, Inc. (COR)|CAH - EV/EBITDA Multiple|Henry Schein - Total Company Value to Operating Income Before Depreciation Ratio|PBH (Prestige Brands) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation Wellgistics Health, Inc. (WGRX)|EV/EBITDA Multiple Jiuzhou 360|Enterprise Value to EBITDA Ratio UPC (Universe Pharmaceuticals)|Enterprise Value to EBITDA Ratio biodexapharma.com BDRX|Total Company Value to Operating Income Before Depreciation Ratio HKPD|BIMI - Enterprise Value to EBITDA Ratio|CJJD (Jiuzhou 360) - Company Value to EBITDA|WBA - EV/EBITDA Multiple